Intrinsic Value of S&P & Nasdaq Contact Us

Edgewise Therapeutics, Inc. EWTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
44/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$38.67
+14.7%

Edgewise Therapeutics, Inc. (EWTX) has 19 known insider and institutional holders on record. The largest holder is OrbiMed Genesis GP LLC with 13,497,456 shares. Other notable holders include Novo Holdings A/S and ORBIMED ADVISORS LLC.

Over the last 12 months, insiders have made 40 transactions in EWTX stock — 14 buys (valued at $3.85M) and 13 sells (valued at $5.79M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

EWTX Insider Ownership

Top Holder
OrbiMed Genesis GP LLC
13,497,456 shares
Buys (12 mo)
14
$3.85M value
Sells (12 mo)
13
$5.79M value
12-Month Transaction Activity
Buy 35%
Sell 33%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Orbimed Genesis Gp Llc Director 13,497,456 2022-05-20
100%
2 Novo Holdings A/s 10 Percent Owner 6,071,703 2022-09-16
45%
3 Orbimed Advisors Llc 10 Percent Owner 443,792 2025-04-04
3%
4 Martin Christopher Nathan Director 45,150 2025-11-24
0%
5 Nofi Michael Chief Financial Officer 43,750 2025-11-13
0%
6 Koch Kevin President and CEO 30,615 2025-08-14
0%
7 Root Jonathan D Director 30,000 2025-06-18
0%
8 Brege Laura Director 30,000 2025-06-18
0%
9 Edris Badreddin Director 30,000 2025-06-18
0%
10 Thompson Peter A. 10 Percent Owner 30,000 2025-06-18
0%
11 Morris Arlene Director 30,000 2025-06-18
0%
12 Fox Jonathan C Director 24,514 2026-04-03
0%
13 Russell Alan J Chief Scientific Officer 23,400 2025-11-13
0%
14 Blaustein Robert Chief Development Officer 17,500 2025-08-14
0%
15 Derakhshan Behrad Chief Business Officer 17,344 2025-08-14
0%
16 Carruthers R Michael Chief Financial Officer 17,344 2025-08-14
0%
17 Moore John R General Counsel 10,214 2025-08-14
0%
18 Donovan Joanne M. CMO 9,597 2026-04-02
0%
19 Semigran Marc Chief Development Officer 6,716 2024-12-27
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-04-01 Fox Jonathan C Director RSU Award 339 - -
2026-04-01 Donovan Joanne M. CMO Informative Sell 28,662 $32.31 $926.1K
2026-03-31 Donovan Joanne M. CMO Informative Sell 21,338 $32.12 $685.31K
2026-03-27 Donovan Joanne M. CMO Informative Sell 6,735 $30.98 $208.64K
2026-01-21 Edris Badreddin Director Option Exercise (Sell) 13,690 $0.39 $5.34K
2026-01-02 Fox Jonathan C Director RSU Award 473 - -
2025-11-19 Martin Christopher Nathan Director RSU Award 45,150 $22.34 $1.01M
2025-11-19 Martin Christopher Nathan Officer Unknown - - -
2025-11-12 Russell Alan J Chief Scientific Officer Informative Sell 100,000 $21.12 $2.11M
2025-11-10 Nofi Michael Chief Financial Officer RSU Award 43,750 - -
2025-11-10 Nofi Michael Officer Unknown - - -
2025-11-11 Fox Jonathan C Director Informative Buy 10,700 $18.64 $199.4K
2025-10-01 Fox Jonathan C Director RSU Award 728 - -
2025-08-26 Russell Alan J Chief Scientific Officer Informative Sell 100,000 $14.60 $1.46M
2025-08-12 Blaustein Robert Chief Development Officer RSU Award 17,500 - -
2025-08-12 Russell Alan J Chief Scientific Officer Option Exercise (Sell) 5,781 - -
2025-08-12 Derakhshan Behrad Chief Business Officer Option Exercise (Sell) 5,781 - -
2025-08-12 Carruthers R Michael Chief Financial Officer Option Exercise (Sell) 5,781 - -
2025-08-12 Donovan Joanne M. CMO Option Exercise (Sell) 5,781 - -
2025-08-12 Moore John R General Counsel Informative Sell 2,098 $13.39 $28.1K
2025-08-12 Koch Kevin President and CEO Informative Sell 7,972 $13.39 $106.76K
2025-07-01 Fox Jonathan C Director RSU Award 858 - -
2025-06-16 Edris Badreddin Director RSU Award 30,000 $14.68 $440.4K
2025-06-16 Fox Jonathan C Director RSU Award 30,000 $14.68 $440.4K
2025-06-16 Brege Laura Director RSU Award 30,000 $14.68 $440.4K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message